$5.21
0.15[2.96%]
Last update: 9:25AM Get Real Time Here
Sophia Genetics
(NASDAQ:SOPH)Sophia Genetics Stock (NASDAQ:SOPH), Analyst Ratings, Price Targets, Predictions
Sophia Genetics SA has a consensus price target of $9.75, established from looking at the 18 latest analyst ratings. The last 3 analyst ratings were released from BTIG, RBC Capital, and RBC Capital on March 6, 2024, March 6, 2024, and January 12, 2024. With an average price target of $8 between BTIG, RBC Capital, and RBC Capital, there's an implied 53.55% upside for Sophia Genetics SA from these 3 analyst ratings.
Analyst Firms Making Recommendations1
BTIG
RBC Capital
Credit Suisse
Morgan Stanley
Credit Suisse
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Sophia Genetics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/06/2024 | SOPH | Buy Now | Sophia Genetics | $5.21 | 53.55% | BTIG | Mark Massaro | $7 → $8 | Maintains | Buy | Get Alert |
| 03/06/2024 | SOPH | Buy Now | Sophia Genetics | $5.21 | 53.55% | RBC Capital | Conor McNamara | → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 01/12/2024 | SOPH | Buy Now | Sophia Genetics | $5.21 | 53.55% | RBC Capital | Conor McNamara | → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 11/29/2023 | SOPH | Buy Now | Sophia Genetics | $5.21 | 53.55% | RBC Capital | Conor McNamara | → $8 | Initiates | → Outperform | Get Alert |
| 05/10/2023 | SOPH | Buy Now | Sophia Genetics | $5.21 | -4.03% | Credit Suisse | Rich Hilliker | $2.25 → $5 | Maintains | Neutral | Get Alert |
| 05/10/2023 | SOPH | Buy Now | Sophia Genetics | $5.21 | 91.94% | Morgan Stanley | Tejas Savant | $11 → $10 | Maintains | Overweight | Get Alert |
| 03/08/2023 | SOPH | Buy Now | Sophia Genetics | $5.21 | 111.13% | Morgan Stanley | Tejas Savant | $12 → $11 | Maintains | Overweight | Get Alert |
| 01/03/2023 | SOPH | Buy Now | Sophia Genetics | $5.21 | 15.16% | BTIG | Mark Massaro | → $6 | Initiates | → Buy | Get Alert |
| 11/23/2022 | SOPH | Buy Now | Sophia Genetics | $5.21 | -61.61% | Credit Suisse | Phil Winslow | → $2 | Initiates | → Neutral | Get Alert |
| 11/09/2022 | SOPH | Buy Now | Sophia Genetics | $5.21 | 130.33% | Morgan Stanley | Tejas Savant | $13 → $12 | Maintains | Overweight | Get Alert |
| 08/10/2022 | SOPH | Buy Now | Sophia Genetics | $5.21 | 149.52% | Morgan Stanley | Tejas Savant | $14 → $13 | Maintains | Overweight | Get Alert |
| 05/11/2022 | SOPH | Buy Now | Sophia Genetics | $5.21 | 168.71% | Morgan Stanley | Tejas Savant | $17 → $14 | Maintains | Overweight | Get Alert |
| 03/16/2022 | SOPH | Buy Now | Sophia Genetics | $5.21 | 226.3% | Morgan Stanley | Tejas Savant | $18 → $17 | Maintains | Overweight | Get Alert |
| 02/15/2022 | SOPH | Buy Now | Sophia Genetics | $5.21 | 245.49% | Morgan Stanley | Tejas Savant | $23 → $18 | Maintains | Overweight | Get Alert |
| 08/17/2021 | SOPH | Buy Now | Sophia Genetics | $5.21 | 360.65% | Morgan Stanley | Tejas Savant | — | Initiates | → Overweight | Get Alert |
| 08/17/2021 | SOPH | Buy Now | Sophia Genetics | $5.21 | — | Cowen & Co. | Doug Schenkel | — | Initiates | → Outperform | Get Alert |
| 08/17/2021 | SOPH | Buy Now | Sophia Genetics | $5.21 | 322.26% | Credit Suisse | Katie Tryhane | — | Initiates | → Outperform | Get Alert |
| 08/17/2021 | SOPH | Buy Now | Sophia Genetics | $5.21 | 341.46% | JP Morgan | Tycho Peterson | — | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Sophia Genetics (SOPH)?
The latest price target for Sophia Genetics (NASDAQ: SOPH) was reported by BTIG on March 6, 2024. The analyst firm set a price target for $8.00 expecting SOPH to rise to within 12 months (a possible 53.55% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sophia Genetics (SOPH)?
The latest analyst rating for Sophia Genetics (NASDAQ: SOPH) was provided by BTIG, and Sophia Genetics maintained their buy rating.
When was the last upgrade for Sophia Genetics (SOPH)?
There is no last upgrade for Sophia Genetics.
When was the last downgrade for Sophia Genetics (SOPH)?
There is no last downgrade for Sophia Genetics.
When is the next analyst rating going to be posted or updated for Sophia Genetics (SOPH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sophia Genetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sophia Genetics was filed on March 6, 2024 so you should expect the next rating to be made available sometime around March 6, 2025.
Is the Analyst Rating Sophia Genetics (SOPH) correct?
While ratings are subjective and will change, the latest Sophia Genetics (SOPH) rating was a maintained with a price target of $7.00 to $8.00. The current price Sophia Genetics (SOPH) is trading at is $5.21, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.